To evaluate the combined effect of Unani formulations in patient suffering from Multiple Joint Pai
Phase 2
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2020/03/024350
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age between 18-60 years
2.Both gender
3.Diagnosed cases of RA according to 2010 ACR/EULAR classification criteria (Score of >=6/10)
4.Patients who will give consent and able to do follow up
Exclusion Criteria
1.Patients below 18 and above 60 years
2.Patients suffering from systemic illness like Hypertension, DM, Malignancy, Liver or Kidney dysfunction
3.Patients suffering from Multiple joints pain other than RA / Extra articular manifestation
4.Patients had received Methotrexate and/or other DMARDs within 01 month prior to enrolment
5.Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method